The Primary
Care Companionfor CNS Disorders

Psychiatry

Letter to the Editor August 13, 2004

A Case Report of Fluoxetine- and Venlafaxine-Induced Hair Loss

Edward C. O'Bryan III, MS; Robert P. Albanese, MD

Prim Care Companion J Clin Psychiatry 2004;6(4):181-181

Article Abstract

Letter to the Editor

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 26 • 2024 • Number 6

Read the Current Issue

Narrative Review

Dextromethorphan-Quinidine for Agitation in Dementia

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Intervention to Enhance Mental Health Competency

Original Research

Evolution of Treatment Modalities for PTSD

Rounds in the General Hospital

Etiology, Prevention, and Management of TD

Rounds in the General Hospital

Comorbid Bipolar Disorder and PTSD

View current Issue

Letter to the Editor

Smartphone Applications: Therapy at Your Fingertips

August 20, 2024

Dr Modesto-Lowe and colleagues discuss the advancements in smartphone applications for psychiatry, as well as some of the risks.

Vania Modesto-Lowe, Sofia Adams, Amanda Rossi

Letter to the Editor

A Mnemonic for Psychiatric History of Presenting Illness

July 18, 2024

In this letter to the editor, Dr Aljeshi presents a mnemonic created to help clinicians obtain a psychiatric history.

Letter to the Editor

Intersection of ChatGPT and Reddit

June 4, 2024

The authors discuss the interplay of online social media support groups and interactive chatbots, which may represent a new realm of mental health support.

Kripa Ahuja, Grace DeSena, David Spiegel

A Case Report of Fluoxetine- and Venlafaxine-Induced Hair Loss

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

ELSEWHERE:

FOLLOW US:

A Case Report of Fluoxetine- and Venlafaxine-Induced Hair Loss

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

Related Articles

Smartphone Applications: Therapy at Your Fingertips

A Mnemonic for Psychiatric History of Presenting Illness

Intersection of ChatGPT and Reddit

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles